Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2009
10/22/2009WO2009106745A3 Method for enantio-selective preparation of sulphoxides
10/22/2009WO2009102428A3 1,3-OXAZEPAN-2-ONE AND 1,3-DIAZEPAN-2-ONE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1
10/22/2009WO2009100120A3 Pyridinyl-substituted piperazinyl oxoethyl tetrahydropyrazolopyridines
10/22/2009WO2009077956A3 HETEROCYCLIC INHIBITORS OF AN Hh-SIGNAL CASCADE, MEDICINAL COMPOSITIONS BASED THEREON AND METHODS FOR TREATING DISEASES CAUSED BY THE ABERRANT ACTIVITY OF AN Hh-SIGNAL SYSTEM
10/22/2009WO2008110355A8 Quinoline derivatives as fungicides
10/22/2009WO2008062480A3 An improved process for the preparation of rimonabant
10/22/2009US20090264659 Salts of benzimidazole derivative with amines and process for manufacturing the same
10/22/2009US20090264658 Salts of benzimidazole derivative with amines and process for manufacturing the same
10/22/2009US20090264656 Method for manufacture of sertindole
10/22/2009US20090264650 Prophylactic/Therapeutic Agent for Diabetes
10/22/2009US20090264647 Benzoimidazole compounds
10/22/2009US20090264646 Benzoimidazole compounds
10/22/2009US20090264645 Benzoimidazole compounds
10/22/2009US20090264474 Sulfonamides as trpm8 modulators
10/22/2009US20090264471 Compounds, Compositions and Methods Comprising Triazole Derivatives
10/22/2009US20090264468 Methods for treating a disease in which Rho kinase is involved
10/22/2009US20090264467 Agents and crystals for improving excretory potency of urinary bladder
10/22/2009US20090264466 Certain Chemical Entities, Compositions and Methods
10/22/2009US20090264451 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents
10/22/2009US20090264444 Organic compounds
10/22/2009US20090264438 Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form alpha
10/22/2009US20090264437 4-Piperazinyl-Pyrimidine Compounds Suitable for Treating Disorders that Respond to Modulation of the Dopamine D3 Receptor
10/22/2009US20090264435 Novel Aryl- and Heteroarylpiperazines
10/22/2009US20090264428 Renin Inhibitors
10/22/2009US20090264427 3-Cyanoquinolines, Methods for Preparation and Use as Insulin-like Growth Factor Inhibitors
10/22/2009US20090264426 Bicyclic aromatic substituted pyridone derivative
10/22/2009US20090264424 Vanilloid receptor ligands and their use in treatments
10/22/2009US20090264419 CYCLIC MALONAMIDES AS INHIBITORS OF Abeta PROTEIN PRODUCTION
10/22/2009US20090264418 such as [5-(4-cyclopentyl-piperazine-1-carbonyl)-1H-indol-2-yl]-pyrrolidin-1-yl-methanone, useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors
10/22/2009US20090264417 N-sulfonyl heterocyclic ring such as piperazine connected via sulfonyl group to another fused heterocyclic ring such as benzothiophene or indoline; peroxisome proliferator-activated receptor (PPAR); obesity, diabetes, hyperinsulinemia, metabolic syndrome X, polycystic ovary syndrome
10/22/2009US20090264416 N-benzyl,n'-arylcarbonylpiperazine derivatives
10/22/2009US20090264407 Substituted Sulfonamide Compounds
10/22/2009US20090264403 Novel azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
10/22/2009US20090264400 Substituted Sulfonamide Compounds
10/22/2009US20090263353 Novel Sulphonylpyrroles as Inhibitors of Hdac S Novel Sulphonylpyrroles
10/22/2009US20090263322 Octahydro-indolizine and quinolizine and hexahydro-pyrrolizines
10/22/2009DE102008019907A1 Pyridazinonderivate Pyridazinone derivatives
10/22/2009CA2725441A1 Indoles as modulators of nicotinic acetylcholin receptor subtype alpha-71
10/22/2009CA2721630A1 Indoles as modulators of nicoticic acetylcholine receptor subtype alpha-7
10/22/2009CA2721240A1 Tertiary amine derivatives as phosphodiesterase-4 inhibitors
10/22/2009CA2721203A1 Inhibitors of protein phosphatase-1 and uses thereof
10/22/2009CA2720559A1 Pyridazinone glucokinase activators
10/22/2009CA2720524A1 Pyrrolidinone glucokinase activators
10/22/2009CA2720215A1 Novel estrogen receptor ligands
10/22/2009CA2719789A1 4-benzylidene-3-methylpiperidine aryl carboxamide compounds useful as faah inhibitors
10/22/2009CA2719785A1 Ether benzylidene piperidine aryl carboxamide compounds
10/22/2009CA2719784A1 Ether benzylidene piperidine 5-membered aryl carboxamide compounds
10/22/2009CA2718538A1 Quinoline derivatives as axl kinase inhibitors
10/22/2009CA2717087A1 4-[3-(aryloxy)benzylidene]-3-methyl piperidine 5-membered aryl carboxamides
10/22/2009CA2716886A1 4-[3-(aryloxy)benzylidene]-3-methyl piperidine aryl carboxamide compounds
10/21/2009EP2110375A1 Phosphodiesterase-4 inhibitors belonging to the tertiary amine class
10/21/2009EP2109608A1 Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
10/21/2009EP2109607A1 Pyrrolo[3, 2-a]pyridine derivatives for inhibiting ksp kinesin activity
10/21/2009EP1979320B1 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS
10/21/2009EP1971601B1 N4-phenyl-quinazoline-4 -amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
10/21/2009EP1853582B1 Heterocyclylamide-substituted imidazoles
10/21/2009EP1608374B9 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
10/21/2009EP1515724B1 Mitotic kinesin inhibitors
10/21/2009EP1513531B1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
10/21/2009EP1492785B9 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
10/21/2009EP1463506B1 Substituted quinazoline derivatives as inhibitors of aurora kinases
10/21/2009EP1448526B1 Piperidine-based mch antagonists for treatment of obesity and cns disorders
10/21/2009EP1426365B9 3-phenoxy-4-pyridazinol derivative and herbicide composition containing the same
10/21/2009EP1280776B1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
10/21/2009CN101563341A Piperidine derivative used for treating chemokine receptor 5 mediated diseases
10/21/2009CN101563340A 2-benzimidaz0lyl-6-m0rph0lin0-4-piperidin-4-ylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders
10/21/2009CN101563339A 2 -benzimidazolyl- 6 -morpholino-4- (azetidine, pyrrolidine, piperidine or azepine) pyrimidine derivatives as PI3K and MTOR inhibitors for the treatment of proliferative disorders
10/21/2009CN101563338A MAPK/ERK kinase inhibitors
10/21/2009CN101563337A Indole compounds
10/21/2009CN101563336A Heterocyclic organic compounds for the treatment of in particular melanoma
10/21/2009CN101563330A Benzoyl amino heterocyclyl compounds as glucokinase (GLK) activators
10/21/2009CN101563322A 1H-indole-2-carboxylic acid derivatives useful as PPAR modulators
10/21/2009CN101563319A Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
10/21/2009CN101560203A Z-configuration anabasine compound and preparation method thereof
10/21/2009CN101560186A Novel organic electroluminescent compounds and organic electroluminescent device using the same
10/21/2009CN101560158A Novel organic electroluminescent compounds and organic electroluminescent device using the same
10/21/2009CN101558758A L-alpha-amino acid ester contained Z-configuration anabasine pesticide and preparation method thereof
10/20/2009US7605273 P38 map kinase inhibitors; inflammatory bowel disease, rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease, and congestive heart failure
10/20/2009US7605268 5-methoxy-2-{[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfanyl}-1H-benzimidazole; chemical intermediates for safer oxidation of the thioether intermediate to give the sulfinyl derivative, omeprazole; ("prazoles", antisecretory agents); by-product inhibition
10/20/2009US7605176 β-ketoamide compounds with MCH antagonistic activity
10/20/2009US7605164 Compositions and methods for treating heart failure
10/20/2009US7605162 Indole-3-alkyl-N-piperazine ring substituted with quinoline ring or derivatives; high affinity for both the dopamine D2 receptor and the serotonin reuptake site; nervous system disorders, such as anxiety disorders, depression, Parkinson's disease, and schizophrenia
10/20/2009US7605159 Cathepsin cysteine protease inhibitors and their use
10/20/2009US7605158 Carbamoyl-type benzofuran derivatives
10/20/2009US7605154 Substituted Thiazolo [4,5-d]pyrimidines as protein kinase inhibitors
10/20/2009CA2585898C Use of (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4-thaizolyl)methyl)amino)-carbonyl)valinyl)amino)-2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane in combination with another protease inhibitor for treating hiv infection
10/20/2009CA2527093C 3-fluoro-piperidines as nmda/nr2b antagonists
10/20/2009CA2469821C Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5
10/20/2009CA2456127C Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
10/20/2009CA2450122C Novel heterocyclic antibacterial compounds
10/20/2009CA2407371C Quinazoline derivatives for the treatment of tumours
10/20/2009CA2393303C Meglumine salt of a specific quinolinecarboxylic acid compound
10/20/2009CA2385130C Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases
10/20/2009CA2368843C Neurotrophic substituted pyrimidines
10/20/2009CA2364662C 3-phenylpyridine derivatives and their use as nk-1 receptor antagonists
10/20/2009CA2214793C Novel intermediates and process for the manufacture of camptothecin derivatives (cpt-11) and related compounds
10/15/2009WO2009126672A2 2-alkynyl-6-pyridin-2-yl-pyridazinones, 2-alkynyl-6-pyridin-2-yl-dihydropyridazinones, 2-alkynyl-6-pyrimidin-2-yl-pyridazinones and 2-alkynyl-6-pyrimidin-2-yl-dihydropyridazinones and their use as fungicides
10/15/2009WO2009126584A1 Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors
10/15/2009WO2009126535A1 Compounds and compositions as modulators of gpr119 activity
10/15/2009WO2009126530A2 Cgrp receptor antagonists
1 ... 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 ... 1080